Skip to content

Effects of Anahil and Novafen tablets in third molar dental surgery

Comparison of Anahil and Novafen Capsules in Reducing Pain, Swelling, Trismus after mandibular third molar surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190618043934N11
Enrollment
27
Registered
2021-06-19
Start date
2021-06-05
Completion date
Unknown
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention 1: Intervention group: Intervention group 1: Patients receiving novafen (acetaminophen 325 mg, ibuprofen 200 mg and caffeine 40 mg, Elahi Medical Company, Iran) after surgery. Interventi

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Bilateral candidate for mandibular third molars Having informed consent to enter the study

Exclusion criteria

Exclusion criteria: Having systemic disease Having local infections such as pericoronitis Smoking History of taking oral contraceptives during the last 4 weeks Poor oral health Pregnancy Allergy to pineapple and plant compounds Having coagulation problems Use of other drugs during the study period

Design outcomes

Primary

MeasureTime frame
Trismus, pain and swelling. Timepoint: Before surgery, one and three days after surgery. Method of measurement: Patients' pain using visual analog classification criteria (0 indicates no pain and 10 indicates maximum pain), swelling by measuring the corner of the mouth to the connection of the ear lobe following the protrusion of the cheek and the degree of trismus by measuring the intercostal distance using a The ruler is measured and the results are reported in millimeters.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZabihullah Mohaghegh

Birjand University of Medical Sciences

oabstudent@gmail.com+98 56 3232 3232

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026